Previous Close | 1.8500 |
Open | 1.8500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 40.00 |
Expire Date | 2024-07-19 |
Day's Range | 1.8500 - 1.8500 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Chief People Officer Paul Jones sold 2,714 shares of Usana Health Sciences Inc (NYSE:USNA) on May 22, 2024, as reported in a recent SEC Filing.
USANA Health Sciences, Inc., a leader in global nutrition, is proud to announce its Celavive Postbiotic Barrier Balm was recently named on BELLA magazine's 2024 Best in Skincare award list. This elite list features skincare products carefully selected to cater to all skin types and concerns and help transform skincare routines.
Key Insights USANA Health Sciences' estimated fair value is US$62.00 based on 2 Stage Free Cash Flow to Equity USANA...